CNPR Market Analysis 3 — Questions and Answers
Question 1: Which data source is most commonly used by pharmaceutical companies to track real-world prescription trends by geography and physician specialty?
- FDA adverse event reporting database
- IQVIA (formerly IMS Health) syndicated data (Correct answer)
- CMS Medicare enrollment data
- National Drug Code (NDC) directory
Correct answer: IQVIA (formerly IMS Health) syndicated data
IQVIA (formerly IMS Health) provides syndicated prescription data that tracks dispensing trends by region, specialty, and drug.
Question 2: A rep's territory shows high total prescription volume but low market access due to formulary restrictions. What strategic focus is most appropriate?
- Increase physician call frequency
- Prioritize managed care access and payer discussions (Correct answer)
- Launch a patient education program
- Reduce pricing to gain market share
Correct answer: Prioritize managed care access and payer discussions
When formulary restrictions limit access, the most impactful strategy is working to improve payer coverage and formulary positioning.
Question 3: In pharmaceutical market analysis, what does 'days of therapy' (DOT) measure?
- The length of a clinical trial
- The total number of treatment days provided by dispensed prescriptions (Correct answer)
- Average prescription duration authorized by a physician
- Time from FDA approval to market launch
Correct answer: The total number of treatment days provided by dispensed prescriptions
Days of therapy (DOT) quantifies the total number of days of medication dispensed, accounting for pack size and dosing regimen.
Question 4: Which concept describes the total number of patients who could potentially benefit from a drug in the market?
- Market penetration rate
- Total addressable market (TAM) (Correct answer)
- Return on investment
- Brand equity
Correct answer: Total addressable market (TAM)
Total addressable market (TAM) represents the maximum potential patient population that could use a given product if there were no market barriers.
Question 5: A pharmaceutical company launches a new statin. What is the best way to define the competitive set for market share analysis?
- All prescription drugs sold in the US
- All drugs within the HMG-CoA reductase inhibitor class (Correct answer)
- All cardiovascular drugs regardless of mechanism
- Only branded statin drugs, excluding generics
Correct answer: All drugs within the HMG-CoA reductase inhibitor class
The competitive set for market share analysis should include all drugs with the same mechanism of action — other statins — regardless of brand or generic status.
Question 6: When analyzing physician prescribing data, a 'decile' ranking is used to:
- Group physicians by geographic region
- Rank physicians into ten equal segments by prescription volume (Correct answer)
- Classify physicians by specialty type
- Identify physicians who have stopped prescribing a drug
Correct answer: Rank physicians into ten equal segments by prescription volume
Decile ranking divides physicians into ten equal groups based on their prescribing volume, helping reps prioritize high-value targets.
Question 7: What is 'lifecycle management' in the context of pharmaceutical market strategy?
- Managing the supply chain from manufacturer to patient
- Strategies to extend a drug's commercial value beyond patent expiration (Correct answer)
- Tracking a patient's entire treatment journey
- Managing the FDA regulatory approval timeline
Correct answer: Strategies to extend a drug's commercial value beyond patent expiration
Lifecycle management involves strategies such as new indications, formulations, or combination products to sustain a drug's commercial relevance after patent expiry.
CNPR Market Analysis 3
Which data source is most commonly used by pharmaceutical companies to track real-world prescription trends by geography and physician specialty?